Y. Masaki et al. / Bioorg. Med. Chem. 18 (2010) 567–572
571
v/v) to give compound 2 as pale yellow oil (1.11 g, 93%): 1H NMR
(CDCl3, 500 MHz): d 8.72 (1H, s), 8.38 (1H, s), 7.83 (1H, d, J = 7.5),
7.80 (1H, d, J = 7.5), 7.43 (1H, t, J = 7.5), 7.29 (1H, t, J = 7.5), 6.52
(1H, t, J = 6.0), 4.65–4.62 (1H, m), 4.04 (1H, d, J = 3.5), 3.88 (1H,
dd, J = 3.5, 11.0), 3.78 (1H, dd, J = 3.0, 11.0), 2.68 (1H, dt,
J = 6.0,12.5), 2.49 (1H, ddd, J = 3.5, 6.0, 12.5) 0.92 (9H, s), 0.91
(9H, s), 0.11 (6H, s), 0.08 (6H, s); 13C NMR (CDCl3, 126 MHz): d
158.3, 151.5, 150.2, 149.0, 148.6, 141.7, 133.2, 125.9, 123.2,
121.0, 120.8, 120.6, 88.1, 84.7, 72.0, 62.8, 41.1, 25.8, 25.7, 18.3,
18.0, ꢁ4.7, ꢁ4.8, ꢁ5.5, ꢁ5.6; MS (ESI) calcd for C29H44N6O3SSi2
[M+H]+ 613.2807, found 613.2837.
126 MHz): d 158.4, 151.3, 150.2, 148.9, 148.7, 144.5, 142.2, 142.1,
135.6, 133.1, 130.0, 129.9, 128.1, 128.0, 127.7, 126.8, 125.9,
123.1, 120.9, 120.5, 117.5, 117.4, 113.0, 86.3, 86.0, 85.8, 85.8,
84.9, 74.2, 74.0, 73.5, 73.3, 63.5, 63.3, 58.4, 58.2, 58.1, 55.1, 45.3,
45.2, 44.4, 44.4, 43.3, 43.2, 39.1, 24.6, 24.5, 24.5, 24.4, 23.6, 22.9,
22.8, 22.6, 20.3, 20.3, 20.2, 20.1, 20.0, 19.9; 31P NMR (CDCl3) d
149.4, 149.3; MS (ESI) calcd for C47H52N8O6PS [M+H]+ 887.3463,
found 887.3445.
4.3. Synthesis of oligonucleotides
The synthesis of ODNs was performed in an ABI 392 DNA syn-
thesizer by the standard 1.0-lmol-scale phosphoramidite ap-
4.2.2. 6-N-(Benzothiazoyl-2-yl)deoxyadenosine 3
Compound 2 (1.11 g, 1.81 mmol) was dissolved in dry THF
(20 mL). To the solution were added Et3Nꢀ3HF (0.59 mL, 3.62 mmol)
and triethylamine (0.51 mL, 3.62 mmol). After being stirred at room
temperature for 16 h, the reaction mixture was filtered. The residue
was dissolved in pyridine and precipitated by CHCl3 to give com-
pound 3 as a pale yellow solid (0.618 g, 89%): 1H NMR (DMSO,
500 MHz): d 12.45 (1H, br s), 8.67 (1H, s), 8.65 (1H, s), 7.95 (1H, d,
J = 7.5), 7.68 (1H, d, J = 7.5), 7.41 (1H, t, J = 7.5), 7.26 (1H, t, J = 7.5),
6.46 (1H, t, J = 6.5), 5.36 (1H, br s), 5.05 (1H, br s), 4.44 (1H, br s),
3.90 (br s, 1H), 3.65–3.62 (1H, m), 3.55–3.52 (1H, m), 2.77 (1H, dt,
J = 6.5, 13.0), 2.37–2.32 (1H, m); 13C NMR (DMSO, 126 MHz): d
150.7, 150.3, 142.0, 126.1, 122.9, 121.4, 88.0, 83.8, 70.7, 61.6; MS
(ESI) calcd for C17H16N6O3S [M+H]+ 385.1077, found 385.1091.
proach, which consists of detritylation, coupling, capping, and
iodine oxidation steps. The universal supports III (Glen Research
Inc.) was used for the synthesis of the A6 sequence. Then, the syn-
thesized oligomers were released from the resin by treatment with
a solution of 28% aq NH3 solution at room temperature for 4 h. The
polymer supports were removed by filtration and washed with
0.1 M ammonium acetate buffer (1 mL ꢄ 3). The filtrates were
purified by anion-exchange HPLC to give ODNs.
Oligonucleotide: ODN1: MALDI-TOF Mass (M+H) calcd for
C133H165N46O75P12S+: 4009.2; found: 4006.0.
Oligonucleotide: ODN21: MALDI-TOF Mass (M+H) calcd for
C140H168N47O75P12S2+: 4142.7; found: 4139.6.
Oligonucleotide: ODN22: MALDI-TOF Mass (M+H) calcd for
C140H168N47O75P12S2+: 4142.7; found: 4137.0.
4.2.3. 50-O-(4,40-Dimethoxytrityl)-6-N-(benzothiazoyl-2-yl)deoxy-
adenosine 3a
Oligonucleotide: ODN3: MALDI-TOF Mass (M+H) calcd for
C147H171N48O75P12S3+: 4275.7; found: 4273.4.
Compound 3 (0.716 g, 1.86 mmol) was co-evaporated three
times with dry pyridine and finally dissolved in dry pyridine
(20 mL). To the solution was added 4,40-dimethoxytrityl chloride
(0.757 g, 2.24 mmol). After being stirred at room temperature for
12 h, the mixture was quenched by adding methanol and evapo-
rated in vacuo. The residue was dissolved with CHCl3. The solution
was washed with water. The organic layer was concentrated in va-
cuo. The residue was chromatographed on a column of silica gel
with CHCl3–MeOH (95:5, v/v) containing 0.5% pyridine to give
compound 3a as white foam (1.144 g, 89%): 1H NMR (CDCl3,
500 MHz): d 11.2 (1H, br s), 8.66 (1H, s), 8.55 (1H, s), 7.84 (1H, d,
J = 8.0), 7.74 (1H, d, J = 8.0), 7.10–7.40 (11H, m), 6.69–6.76 (4H,
m), 6.57 (1H, t, J = 6.0), 4.78 (1H, d, J = 3.5), 4.26–4.32 (1H, m),
3.70 (6H, s), 3.44–3.51 (1H, m), 3.38–3.44 (1H, m), 2.96 (1H, dt,
J = 6.5, 13.0), 2.64–2.72 (1H, m); 13C NMR (CDCl3, 126 MHz): d
158.5, 158.4, 151.3, 150.1, 148.8, 148.6, 144.4, 141.9, 135.6,
135.5, 133.0, 129.9, 129.9, 128.0, 127.7, 126.8, 125.9, 123.1,
120.9, 120.7, 120.5, 113.0, 86.5, 86.1, 84.6, 72.3, 63.6, 55.1, 39.9;
MS (ESI) calcd for C38H35N6O5S [M+H]+ 687.2384, found 687.2347.
Oligonucleotide: A1: MALDI-TOF Mass (M+H) calcd for
C132H152N58O64P11S2+: 3977.7; found: 3972.9.
Oligonucleotide: A2: MALDI-TOF Mass (M+H) calcd for
C132H152N58O64P11S2+: 3977.7; found: 3978.0.
Oligonucleotide: A3: MALDI-TOF Mass (M+H) calcd for
C132H152N58O64P11S2+: 3977.7; found: 3974.5.
Oligonucleotide: A4: MALDI-TOF Mass (M+H) calcd for
C132H152N58O64P11S2+: 3977.7; found: 3972.7.
Oligonucleotide: A5: MALDI-TOF Mass (M+H) calcd for
C132H152N58O64P11S2+: 3977.7; found: 3976.0.
Oligonucleotide: A6: MALDI-TOF Mass (M+H) calcd for
C152H176N68O74P13S2+: 4603.8; found: 4599.7.
4.4. Tm measurement
The unmodified oligodeoxynucleotides were purchased from
SIGMA GENOSYS. An appropriate ODN (2
lM) and its complemen-
tary ssDNA (2 M) were dissolved in a buffer consisting of 100 mM
l
NaCl, 10 mM sodium phosphate, and 0.1 mM EDTA adjusted to pH
7.0. The solution was kept at 85 °C for 10 min for complete disso-
ciation of the duplex to single strands, cooled at the rate of
ꢁ1.0 °C/min, and kept 10 °C for 10 min. Then, the melting temper-
atures (Tm) were determined at 260 nm using a UV spectrometer
(Pharma Spec UV-1700™, Shimadzu) by increasing the tempera-
ture at the rate of 1.0 °C/min.
4.2.4. 30-O-[(N,N-Diisopropylamino)-2-cyanoethoxyphosphinyl]-
50-O-(4,40-dimethoxytrityl)-6-N-(benzothiazoyl-2-yl)deoxyade-
nosine 4
Compound 3a (671 mg, 0.98 mmol) was dissolved in dry CH2Cl2
(10 mL). To the solution were added diisopropylamine (82.4
0.58 mmol) and bis-(N,N-diisopropylamino)(2-cyanoethoxy)phos-
phine (324 L) in dry CH2Cl2 (10 mL). After being stirred at room
lL,
l
4.5. CD spectra
temperature for 2.5 h, the mixture was washed with saturated
NaHCO3 solution. The organic layer was evaporated in vacuo. The
residue was chromatographed on a column of silica gel with
CHCl3–MeOH (97:3, v/v) containing 0.5% pyridine to give com-
CD spectra were measured on J-725 Spectroplarimeter, JASCO.
Each oligodeoxynucleotide solutions (5 lM)) were prepared in
pound
4
as white foam (692 mg, 80%): 1H NMR (CDCl3,
10 mM sodium phosphate buffer pH 7.0, 0.1 mM EDTA, and
100 mM NaCl. The solutions were heated to 85 °C and annealed
by slowly cooling to room temperature over a period of 12 h. Spec-
tra were recorded between 220 and 370 nm. Spectra were aver-
aged over 8 scans, which were recorded at 100 nm minꢁ1 with a
response time of 4 s and a bandwidth of 1.0 nm.
500 MHz): d 8.67 (1H, s), 8.54–8.64 (1H, m), 7.85 (1H, d, J = 7.0),
7.75 (1H, d, J = 7.5), 7.30–7.40 (11H, m), 6.69–6.81 (4H, m), 6.48–
6.56 (1H, br s), 4.78–4.8 (1H, m), 4.32–4.42 (1H, m), 3.50–3.92
(10H, m), 3.34–3.48 (2H, m), 2.98–3.09 (1H, m), 2.58–2.82 (2H,
m), 2.44–2.53 (1H, m), 1.13–1.38 (12H, m); 13C NMR (CDCl3,